EFTR Historical PE Ratio image   This EFTR PE ratio history page last updated 8/11/2022
EFTR Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/9/2022
0.65-0.17-0.68NA
Q1 2022
5/10/2022
2.400.070.288.6
Q4 2021
3/16/2022
4.070.441.762.3
Q3 2021
11/8/2021
11.120.421.686.6
EFTR PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/9/2022
0.65-0.170.760.9
Q1 2022
5/10/2022
2.400.07NANA
Q4 2021
3/16/2022
4.070.44NANA
Q3 2021
11/8/2021
11.120.42NANA
Quotes delayed 20 minutes

Email EnvelopeFree EFTR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
eFFECTOR Therapeutics (EFTR) is categorized under the Miscellaneous sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ELMS PE Ratio History
ENJY PE Ratio History
ENSC PE Ratio History
ENVX PE Ratio History
EPSN PE Ratio History
ESNT PE Ratio History
ESTC PE Ratio History
EVGO PE Ratio History
EVLV PE Ratio History
EVTC PE Ratio History
How should the EFTR historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like eFFECTOR Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this EFTR Historical PE Ratio page.

What is the average historical PE for EFTR based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The EFTR historical PE ratio using the annualized quarterly earnings method works out to 5.8.

What is the average historical PE for EFTR based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The EFTR historical PE ratio using the TTM earnings method works out to 0.9.

What is the average historical PE for EFTR based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The EFTR historical PE ratio using the annualized median TTM earnings method works out to 0.96.

On this page we presented the EFTR Historical PE Ratio information for eFFECTOR Therapeutics' stock. The average EFTR historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 5.8. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average EFTR historical PE based on this TTM earnings result method is 0.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this EFTR historical PE result, against the recent PE: when this page was posted on 8/10/2022, the most recent closing price for EFTR had been 0.73, and the most recent quarterly earnings result, annualized, was 0.28. Meanwhile, the most recent TTM earnings summed to 0.76. From these numbers, we calculate the recent EFTR PE on 8/10/2022 based on annualized quarterly EPS was 2.6. Based on EFTR's history, that recent PE is low relative to the historical average, with the recent PE 55.2% lower than the historical average PE across our data set for eFFECTOR Therapeutics. Looking at the recent EFTR PE on 8/10/2022 based on TTM EPS, we calculate the ratio at 1.0. Based on EFTR's history, that recent PE is elevated relative to the historical average, with the recent PE 11.1% higher than the historical average PE across our eFFECTOR Therapeutics data set with TTM EPS used in the calculation at each period.

Another interesting EFTR historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for EFTR, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for EFTR, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.17, 0.07, 0.42, and 0.44. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.07 and 0.42 — which gives us the median of 0.24. Basically the way to think about this 0.24 number is this: for the trailing four earnings reports, 0.24 marks the "middle ground" number where EFTR has reported a value higher than 0.24 half the time, and has reported a value lower than 0.24 half the time. Annualizing that median value then gets us to 0.96/share, which we use as the denominator in our next PE calculation. With 0.73 as the numerator (as of 8/10/2022), the calculation is then 0.73 / 0.96 = 0.8 as the EFTR PE ratio as of 8/10/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on EFTR or any other given stock, valuation analysis for EFTR can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate eFFECTOR Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for EFTR. Thanks for visiting, and the next time you need to research EFTR Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: TFCF shares outstanding history, ETFs Holding TNAV, CIE Options Chain.

 

EFTR Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.